3
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous Article

References

Pages 52-60 | Published online: 17 Mar 2010

References

  • Albert A, Regañon E, Saiz J L, Usobiaga P. Physicochemical Studies on Tryptic Digestion of Bovine Fibrinogen. Biochimica et Biophysica Acta 1975; 386: 382–90
  • Alkjaersig N, Fletcher A P, Sherry S. Pathogenesis of the Coagulation Defect Developing during Pathological Plasma Proteolytic (‘Fibrinolytic’) States. II. The Significance, Mechanism, and Consequences of Defective Fibrin Polymerization. Journal of Clinical Investigation 1962; 41: 917–34
  • Alkjaersig N, Davies A, Fletcher A P. Fibrin and Fibrinogen Proteolysis Products: Comparison between Gel Filtration and SDS Polyacrylamide Electrophoresis Analysis. Thrombosis and Haemostasis (Stuttg.) 1977; 38: 524–35
  • Arnesen H. Characterization of Fibrinogen and Fibrin Degradation Products by Isoelectric Focusing in Polyacrylamide Gel. Thrombosis Research 1974; 4: 861–8
  • Astrup T, Müllertz S. Fibrin Plate Method for Estimating Fibrinolytic Activity. Archives of Biochemistry and Biophysics 1952; 40: 346–51
  • Axelsen N H. Intermediate Gel in Crossed and Fused Rocket Immunoelectrophoresis. Quantitative Immunoelectrophoresis. Scandinavian Journal of Immunology, N H Axel-Sen, J Krøll, B. Weeke, 1973; 71–7, Supplementum 1
  • Barg W F, Boggiano E, DeRenzo E C. Interaction of Streptokinase and Human Plasminogen. II. Starch Gel Electrophoretic Demonstration of a Reaction Product with Activator Activity. The Journal of Biological Chemistry 1965; 240: 2944–50
  • Beck E A, Jackson D P. Studies on the Degradation of Human Fibrinogen by Plasmin and Trypsin. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1966; 16: 526–40
  • Bergkvist R. The Proteolytic Enzymes of Aspergillus oryzae. III. A Comparison of the Fibrinolytic and Fibrinogenolytic Effects of the Enzymes. Acta Chemica Scandinavica 1963; 17: 2230–8
  • Bergkvist R, Svärd P O. Studies on the Thrombolytic Activity of a Protease from Aspergillus Oryzae. Acta Physiologica Scandinavica 1964; 60: 363–71
  • Bickford A F, Sokolow M. Fibrinolysis as Related to Urea Solubility of Fibrin. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1961; 5: 480–8
  • Bidwell E. Fibrinolysis of Human Plasma. A Comparison of Fibrinolytic Plasma from Normal Subjects and from Cadaver Blood with Plasmin Prepared by Activation with Chloroform. Biochemical Journal 1953; 55: 497–506
  • Blix S. The fibrinolysis of Plasma Clots under Various Conditions. Acta Medica Scandinavica 1961; 169: 495–502
  • Blombäck B. Subunit Structure of Fibrinogen. Fibrinogen Degradation Products. Scandinavian Journal of Haematology, M Verstraete, J Vermylen, M B Donati, 1971; 71–3, Supplementum 13
  • Blombäck B. Report on the Subcommitee on Nomenclature. Thrombosis et Diathesis haemorrhagica (Stuttg.). 1973; 425–34, Supplementum 54
  • Blombäck B, Blombäck M. The Molecular Structure of Fibrinogen. In: Laki K. The Biological Role of the Clot-Stabilizing Enzymes: Transglutaminase and Factor XIII. Annals of the New York Academy of Sciences 1972; 202: 77–97
  • Blombäck B, Hessel B, Iwanaga S, Reuterby J, Blombäck M. Primary Structure of Human Fibrinogen and Fibrin. I. Cleavage of Fibrinogen with Cyanogen Bromide. Isolation and Characterization of NH2-terminal Fragments of the α (‘A’) Chain. The Journal of Biological Chemistry 1972; 247: 1496–1512
  • Blombäck B, Hogg D H, Gårdlund B, Hessel B, Kudryk B. Fibrinogen and Fibrin Formation. Hemorheology and Thrombosis, A L Copley, S Okamoto. Thrombosis Research. 1976a; 329–46, 8/Supplementum 11
  • Blombäck M, Blombäck B, Holmquist H. Immunological Characterization of Early Fibrinogen Degradation Products. Radioimmunoassay of Fragments Released from the Aα-Chain of Fibrinogen. Thrombosis Research 1976b; 8: 567–77
  • Bock E, Axelsen N H. Comparisons of Antigens: Reaction of Partial Identity. Quantitative Immunoelectrophoresis. Scandinavian Journal of Immunology, N H Axelsen, J Krøll, B Weeke, 1973; 95–9, Supplementum 1
  • Braude R, Altman R, Rouvier J, Aguilar N. Immunoelectrophoretic Studies on the Kinetics of Plasmic Degradation of Human Fibrinogen. Thrombosis and Haemostasis (Stuttg.) 1977; 37: 136–43
  • Brummel M C, Montgomery R. Acrylamide Gel Electrophoresis of the S-Sulfo Derivatives of Fibrinogen. Analytical Biochemistry 1970; 33: 28–35
  • Budzynski A Z, Stahl M, Kopec M, Latallo Z S, Wegrzynowicz Z, Kowalski E. High Molecular Weight Products of the Late Stage of Fibrinogen Proteolysis by Plasmin and their Structural Relation to the Fibrinogen Molecule. Biochimica et Biophysica Acta 1967; 147: 313–23
  • Caspary E A, Kekwick R A. Some Physicochemical Properties of Human Fibrinogen. Biochemical Journal 1957; 67: 41–8
  • Chen R, Doolittle R F. Isolation, Characterization, and Location of a Donor-Acceptor Unit from Crosslinked Fibrin. Proceedings of the National Academy of Sciences of USA 1970; 66: 472–9
  • Claeys H, Vermylen J. Physicochemical and Proenzyme Properties of NH2-terminal Glutamic acid and NH2-terminal Lysine Human Plasminogen. Influence of 6-Aminohexanoic Acid. Biochimica et Biophysica Acta 1974; 342: 351–9
  • Clarke H GM, Freeman T. Quantitative Immunoelectrophoresis of Human Serum Proteins. Clinical Science 1968; 35: 403–13
  • Clemmensen I, Andersen R Bach. Properties of Fibrinogen-Antigenic Material on the Rheumatoid Synovial Membrane and in the Rheumatoid Synovial Fluid. The Journal of Laboratory and Clinical Medicine 1978; 92: 678–89
  • Cooke R D, Holbrook J J. The Calcium-Induced Dissociation of Human Plasma Clotting Factor XIII. Biochemical Journal 1974; 141: 79–84
  • Davies B J. Disc Electrophoresis. II. Method and Application to Human Serum Proteins. Annals of the New York Academy of Sciences 1964; 121: 404–27
  • Dole V P. The Electrophoretic Patterns of Normal Plasma. The Journal of Clinical Investigation 1944; 23: 708–13
  • Dudek G A, Kloczewiak M, Budzynski A Z, Latallo Z S, Kopeć M. Characterization and Comparison of Macromolecular End Products of Fibrinogen and Fibrin Proteolysis by Plasmin. Biochimica et Biophysica Acta 1970; 214: 44–51
  • Fearnley G R, Tweed J M. Evidence of an Active Fibrinolytic Enzyme in the Plasma of Normal People with Observations on Inhibition Associated with the Presence of Calcium. Clinical Science 1953; 12: 81–9
  • Fearnley G R, Revill R, Tweed J M. Observations on the Interaction of Fibrinolytic Activity in Shed Blood. Clinical Science 1952; 11: 309–14
  • Fearnley G R, Balmforth G, Fearnley E. Evidence of A Diurnal Fibrinolytic Rythm with a Simple Method of Measuring Natural Fibrinolysis. Clinical Science 1957; 16: 645–50
  • Ferry J D, Miller M, Shulman S. The Conversion of Fibrinogen to Fibrin. VII. Rigidity and Stress Relaxation of Fibrin Clots; Effect of Calcium. Archives of Biochemistry and Biophysics 1951; 34: 424–36
  • Fletcher A P. Fibrinolytic Dysfibrinogenemias. Federation Proceedings 1965; 24: 822–6
  • Fletcher A P, Alkjaersig N, Fisher S, Sherry S. The Proteolysis of Fibrinogen by Plasmin: The Identification of Thrombin-Clottable Fibrinogen Derivatives which Polymerize Abnormally. The Journal of Laboratory and Clinical Medicine 1966; 68: 780–802
  • Fretto L J, McKee P A. Structure of α-Polymer from in Vitro and in Vivo Highly Cross-linked Human Fibrin. The Journal of Biological Chemistry 1978; 253: 6614–22
  • Fretto L J, Ferguson E W, Steinman H M, McKee P A. Localization of the α-Chain Cross-link Acceptor Sites of Human Fibrin. The Journal of Biological Chemistry 1978; 253: 2184–95
  • Furlan M, Beck E A. Plasmic Degradation of Human Fibrinogen. I. Structural Characterization of Degradation Products. Biochimica et Biophysica Acta 1972; 263: 631–44
  • Furlan M, Beck E A. Plasmic Degradation of Human Fibrinogen. II. Further Characterization of Fragment D. Biochimica et Biophysica Acta 1973; 310: 205–16
  • Furlan M, Kemp G, Beck E A. Plasmic Degradation of Human Fibrinogen. III. Molecular Model of the Plasmin-Resistant Disulfide Knot in Monomeric Fragment D. Biochimica et Biophysica Acta 1975; 400: 95–111
  • Gaffney P J. Localisation of Carbohydrate in the Subunits of Human Fibrinogen and its Plasmin Induced Fragments. Biochimica et Biophysica Acta 1972a; 263: 453–8
  • Gaffney PJ. F. D. P. The Lancet 1972b; II: 1422, (Letter to the Editor)
  • Gaffney P J. Subunit Relationships between Fibrinogen and Fibrin Products. Thrombosis Research 1973; 2: 201–18
  • Gaffney P J. Distinction between Fibrinogen and Fibrin Degradation Products in Plasma. Clinica Chimica Acta 1975; 65: 109–15
  • Gaffney P J. Fibrin(-ogen) Interactions with Plasmin. Haemostasis 1977; 6: 2–25
  • Gaffney P J, Brasher M. Subunit Structure of the Plasmin-Induced Degradation Products of Crosslinked Fibrin. Biochimica et Biophysica Acta 1973; 295: 308–13
  • Gaffney P J, Dobos P. A Structural Aspect of Human Fibrinogen Suggested by its Plasmin Degradation. FEBS Letters 1971; 15: 13–6
  • Gaffney P J, Joe F. The Lysis of Crosslinked Human Fibrin by Plasmin Yields Initially a Single Molecular Complex, D Dimer-E. Thrombosis Research 1979; 15: 673–87
  • Gaffney P J, Lane D A, Brasher M. Soluble High-Molecular-Weight E Fragments in the Plasmin-Induced Degradation Products of Cross-linked Human Fibrin. Clinical Science and Molecular Medicine 1975a; 49: 149–56
  • Gaffney P J, Lane D A, Kakkar V V, Brasher M. Characterization of a Soluble D Dimer-E Complex in Crosslinked Fibrin Digests. Thrombosis Research 1975b; 7: 89–99
  • Gaffney P J, Lord K, Thornes R D. The Action of Brinase in Vitro and in Vivo. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1975c; 34: 914, abstract
  • Gårdlund B, Kowalska-Loth B, Grøndahl N J, Blombäck B. Plasma Degradation Products of Human Fibrinogen. I. Isolation and Characterization of Fragments E and D and their Relation to ‘Disulfide Knots’. Thrombosis Research 1972; 1: 371–88
  • Garner R L, Tillett W S. Biochemical Studies of the Fibrinolytic Activity of Hemolytic Streptococci. II. Nature of the Reaction. The Journal of Experimental Medicine 1934; 60: 255–67
  • Gollwitzer R, Timpl R, Becker U, Furthmayer H. Chemical and Immunological Properties of Reduced and Alkylated Polypeptide Chains of Bovine Fibrinogen. European Journal of Biochemistry 1972; 28: 497–506
  • Gormsen J, Laursen B. Fibrinogen Break-Down Products and Clotting Parameters. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1967; 17: 467–81
  • Gormsen J, Fletcher A P, Alkjaersig N, Sherry S. Enzymic Lysis of Plasma Clots: The Influence of Fibrin Stabilization on Lysis Rates. Archives of Biochemistry and Biophysics 1967; 120: 654–65
  • Gottlieb S F, Celander D R, Guest M M. Effect of Fibrin Stabilizing Factor on Susceptibility of Clots to Fibrinolysis. Federation Proceedings 1959; 18: 58, abstract no. 225
  • Grosskopf W R, Summaria L, Robbins K C. Studies on the Active Center of Human Plasmin. Partial Amino Acid Sequence of a Peptide Containing the Active Center Serine Residue. The Journal of Biological Chemistry 1969; 244: 3590–7
  • Hall C E, Slayter H S. The Fibrinogen Molecule: Its Size, Shape and Mode of Polymerization. The Journal of Biophysical and Biochemical Cytology 1959; 5: 11–6
  • Harboe N, Ingild A. Immunization, Isolation of Immunoglobulins, Estimation of Antibody Titre. Quantitative Immunoelectrophoresis. Scandinavian Journal of Immunology, N H Axelsen, J Krøll, B Weeke, 1973; 161–4, Supplementum 1
  • Harfenist E J, Canfield R E. Degradation of Fibrinogen by Plasmin. Isolation of an Early Cleavage Product. Biochemistry 1975; 14: 4110–7
  • Haverkate F, Timan G. Protective Effect of Calcium in the Plasmin Degradation of Fibrinogen and Fibrin Fragments D. Thrombosis Research 1977; 10: 803–12
  • Hedner U, Nilsson I M. Comparison between a Direct and an Indirect Method for Determining Plasminogen. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1971; 26: 289–94
  • Henderson K W, Nussbaum M. The Mechanism of Enhanced Streptokinase-Induced Clot Lysis Following In-vitro Factor-XIII Inactivation. British Journal of Haematology 1969; 17: 445–53
  • Hudry-Clergeon G, Patural L, Suscillon M. Identification d'un complexe (D-D) E dans les produits de degradation de la fibrine bovine stabilisée par le facteur XIII. Pathologie et Biologie 1974; 22(Suppl.)47–52
  • International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry (prepared by Dybkær R). Approved Recommendation (1978). Quantities and Units in Clinical Chemistry. Clinica Chimica Acta 1979; 96: 157F–183F
  • Jacobsen C D, Hoack J C, Wu K K, Fry G L. Fibrinogen-Fibrin Related Antigen Pattern in Human Blood. Differences between Plasma and Serum from Patients with Disseminated Intravascular Coagulation. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1974; 32: 266–76
  • Jacobsen C D, Fry G L, Wu K K, Southers N J. Fibrinogen-Fibrin Related Antigen Pattern in Human Blood. Incomplete Lysis of Whole Blood Clots by Urokinase. Thrombosis Research 1975; 6: 327–36
  • Jamieson G A, Gaffney P J. Heterogeneity of Fibrin Polymerization Inhibitor. Biochimica et Biophysica Acta 1966; 121: 217–20
  • Jamieson G A, Gaffney P J. Nature of the High Molecular Weight Fraction of Fibrinolytic Digests of Human Fibrinogen. Biochimica et Biophysica Acta 1968; 154: 96–109
  • Johnson A J, Kline D L, Alkjaersig N. Assay Methods and Standard Preparations for Plasmin, Plasminogen and Urokinase in Purified Systems, 1967–1968. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1969; 21: 259–72
  • Kiessling H, Svensson R. Influence of an Enzyme from Aspergillus Oryzae, Protease I, on Some Components of the Fibrinolytic System. Acta Chemica Scandinavica 1970; 24: 569–79
  • Kochwa S, Jonathan-Assa S, Strauss A, Kaufmann H, de Vries A. Antigenic Structure of Human and Bovine Fibrinogen and their Fibrinogenolytic Degradation Products. Bulletin of the Research Council of Israel Section E Experimental Medicine 1960; 8E: 69–71
  • Kopeć M, Teisseyre E, Dudek-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo Z S. Studies in the ‘Double D’ Fragment from Stabilized Bovine Fibrin. Thrombosis Research 1973; 2: 283–92
  • Kowalska-Loth B, Gårdlund B, Egberg N, Blombäck B. Plasmic Degradation Products of Human Fibrinogen. II. Chemical and Immunological Relation Between Fragment E and N-DSK. Thrombosis Research 1973; 2: 423–50
  • Kowalski E. Fibrinogen Derivatives and Their Biologic Activities. Seminars in Hematology 1968; 5: 45–59
  • Kudryk B J, Collen D, Woods K R, Blombäck B. Evidence for Localization of Polymerization Sites in Fibrinogen. The Journal of Biological Chemistry 1974; 249: 3322–5
  • Laki K, Lorand L. On Solubility of Fibrin Clots. Science 1948; 108: 280
  • Larrieu M J, Marder V J, Inceman S. Effects of Fibrinogen Degradation Products on Platelets and Coagulation. Diffuse Intravascular Clotting. Thrombosis et Diathesis haemorrhagica (Stuttg.), F Roller, F Streuli, 1966; 215–26, Supplementum 20
  • Latallo Z S, Budzynski A Z, Lipinski B, Kowalski E. Inhibition of Thrombin and of Fibrin Polymerization, Two Activities Derived from Plasmin-Digested Fibrinogen. Nature (Lond.) 1964; 203: 1184–5
  • Laurell C B. Antigen-Antibody Crossed Electrophoresis. Analytical Biochemistry 1965; 10: 358–61
  • Laurell C B. Quantitative Estimation of Proteins by Electrophoresis in Agarose Gel Containing Antibodies. Analytical Biochemistry 1966; 15: 45–52
  • Lorand L. Fibrin Clots. Nature (Lond.) 1950; 166: 694–5
  • Lorand J B, Pilkington T RE, Lorand L. Inhibitors of Fibrin Cross-linking: Relevance for Thrombolysis. Nature 1966; 210: 1273–4
  • Lorand L, Downey J, Gotoh T, Jacobsen A, Kokura S. The Transpeptidase System which Crosslinks Fibrin by γ-glutamyl-ϵ-lysine Bonds. Biochemical Biophysical Research Communications 1968; 31: 222–30
  • Lorand L, Urayama T, de Kiewiet J WC, Nossel H L. Diagnostic and Genetic Studies on Fibrin-Stabilizing Factor with a New Assay Based on Amine Incorporation. Journal of Clinical Investigation 1969; 48: 1054–64
  • Lowry O H, Rosebrough N I, Farr A L, Randall R J. Protein Measurement with the Folin Phenol Reagent. The Journal of Biological Chemistry 1951; 193: 265–75
  • Ly B, Kierulf P, Arnesen H. Molecular Aspects of the Clottable Proteins of Human Plasma During Fibrinogenolysis. Thrombosis Research 1974; 5: 301–14
  • Mancini G, Carbonara A O, Heremans J F. Immunochemical Quantitation of Antigens by Single Radial Immunodiffusion. Immunochemistry 1965; 2: 235–54
  • Marder V J, Budzynski A Z. Degradation Products of Fibrinogen and Crosslinked Fibrin — Projected Clinical Applications. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1974; 32: 49–56
  • Marder V J, Budzynski A Z, James H L. High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin. III. Their NH2-terminal Amino Acids and Comparisons with the NH2-terminal Disulfide Knot. The Journal of Biological Chemistry 1972; 247: 4775–81
  • Marder V J, Shulman N R, Carroll W R. The Importance of Intermediate Degradation Products of Fibrinogen in Fibrinolytic Hemorrhage. Transactions of the Association of American Physicians 1967; 80: 156–67
  • Marder V J, Shulman N R, Carroll W R. High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin. I. Physicochemical and Immunological Characterization. The Journal of Biological Chemistry 1969; 244: 2111–9
  • Marguerie G, Chagniel G, Suscillon M. The Binding of Calcium to Bovine Fibrinogen. Biochimica et Biophysica Acta 1977; 490: 94–103
  • Matačić S, Loewy A G. The Identification of Isopeptide Crosslinks in Insoluble Fibrin. Biochemical Biophysical Research Communications 1968; 30: 256–62
  • Mattock P, Esnouf M P. Differences in the Subunit Structure of Human Fibrin formed by the Action of Arvin, Reptilase, and Thrombin. Nature New Biology 1971; 233: 277–9
  • McClintock D K, Englert M E, Dziobkowski C, Snedeker E H, Bell P H. Two Distinct Pathways of the Streptokinase-Mediated Activation of Highly Purified Human Plasminogen. Biochemistry 1974; 13: 5334–44
  • McDonagh R P, McDonagh J, Duckert F. The Influence of Fibrin Crosslinking on the Kinetics of Urokinase-Induced Clot Lysis. British Journal of Haematology 1971; 21: 323–32
  • McKee P A, Rogers L A, Marler E, Hill R L. The Subunit Polypeptides of Human Fibrinogen. Archives of Biochemistry and Biophysics 1966; 116: 271–9
  • McKee P A, Mattock P, Hill R L. Subunit Structure of Human Fibrinogen, Soluble Fibrin, and Crosslinked Insoluble Fibrin. Proceedings of the National Academy of Sciences 1970; 66: 738–44
  • Merskey C, Lalezari P, Johnson A J, Rapid A. Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum. Proceedings of the Society for Experimental Biology and Medicine 1969; 131: 871–5
  • Merskey C, Johnson A J, Lalezari P. Increase in Fibrinogen and Fibrin-Related Antigen in Human Serum Due to in Vitro Lysis of Fibrin by Thrombin. Journal of Clinical Investigation 1972; 51: 903–11
  • Mihalyi E. Review of the Physicochemistry of Bovine Fibrinogen with Special Reference to Its Proteolytic Fragmentation. Fibrinogen: Structural, Metabolic and Pathophysiologic Aspects. Thrombosis et Diathesis haemorrhagica (Stuttg.), K M Brinkhous, P A Owren, I S Wright, H R Roberts, S Hinnom, T H Kiesselbach, 1970; 43–61, Supplementum 39
  • Mihalyi E, Godfrey J E. Digestion of Fibrinogen by Trypsin. I. Kinetic Studies of the Reaction. Biochimica et Biophysica Acta 1963; 67: 73–89
  • Mihalyi E, Godfrey J E. Kinetic Studies of the Digestion of Fibrinogen by α-Chymotrypsin. Biochimica et Biophysica Acta 1967; 132: 94–103
  • Mihalyi E, Towne D W. Behaviour of Fibrinogen Fragments D and E in Gel Filtration Experiments. Thrombosis Research 1976; 8: 1–15
  • Mihalyi E, Weinberg R M, Towne D W, Friedman M E. Proteolytic Fragmentation of Fibrinogen. I. Comparison of the Fragmentation of Human and Bovine Fibrinogen by Trypsin and Plasmin. Biochemistry 1976; 15: 5372–81
  • Mills D A. A Molecular Model for the Proteolysis of Human Fibrinogen by Plasmin. Biochimica et Biophysica Acta 1972; 263: 619–30
  • Mosesson M W, Finlayson J S. Subfractions of Human Fibrinogen. Preparation and Analysis. The Journal of Laboratory and Clinical Medicine 1963; 62: 663–74
  • Mosesson M W, Finlayson J S, Umfleet R A, Galanakis D. Human Fibrinogen Heterogeneities. I. Structural and Related Studies of Plasma Fibrinogens which are High Solubility Catabolic Intermediates. The Journal of Biological Chemistry 1972; 247: 5210–9
  • Mosesson M W, Finlayson J S, Galanakis D. The Essential Covalent Structure of Human Fibrinogen Evinced by Analysis of Derivatives Formed during Plasmic Hydrolysis. The Journal of Biological Chemistry 1973; 248: 7913–29
  • Müllertz S. Formation and Properties of the Activator of Plasminogen and of Human and Bovine Plasmin. The Biochemical Journal 1955; 61: 424–34
  • Nandi M, Lewis G P. Thin-Layer Acrylamide Gel Electrophoresis. Journal of Clinical Pathology 1970; 23: 727–9
  • Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Revue d'Hémato-logie 1958; 13: 320–8
  • Niewiarowski S, Nandi M. Acrylamide Gel Electrophoresis of Fibrinogen and Fibrin Degradation Products. British Journal of Haematology 1971; 21: 71–82
  • Niewiarowski S, Latallo S, Stachurska J. Apparition d'un inhibiteur de la thromboplastinofor-mation au cours de la protéolyse de fibrinogène. Revue d'Hématologie 1959; 14: 118–28
  • Niléhn J.-E. Split Products of Fibrinogen after Prolonged Interaction with Plasmin. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1967; 18: 89–100
  • Nissen U. De naturligt forekommende proteaseinhibitorers kemi. Thesis, Technical University, Copenhagen 1964
  • Nussenzweig V, Seligmann M. Analyse, par des méthodes immunochimiques, de la dégradation par la plasmine du fibrinogène humain et de la fibrine, a différents stades. Revue d'Hématologie 1960; 15: 451–66
  • Nussenzweig V, Seligmann M, Pelmont J, Grabar P. Les produits de degradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques. Annales de L'Institut Pasteur 1961a; 100: 377–89
  • Nussenzweig V, Seligmann M, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. II. Etude immunologique: Mise en évidence d'anticorps anti-fibrinogène natif possédant des spécificités différentes. Annales de L'Institut Pasteur 1961b; 100: 490–508
  • Ogston D, Ogston C M. In Vitro Studies on a Proteolytic Enzyme from Aspergillus Oryzae (Protease I). Thrombosis et Diathesis haemorrhagica (Stuttg.) 1968; 19: 136–44
  • Olexa S A, Budzynski A Z, Marder V J. Modification of High Molecular Weight Plasmic Degradation Products of Human Crosslinked Fibrin. Biochimica et Biophysica Acta 1979; 576: 39–50
  • Ornstein L. Disc Electrophoresis. I. Background and Theory. Annals of the New York Academy of Sciences 1964; 121: 321–49
  • Ouchterlony ö. Antigen-Antibody Reaction in Gels. Arkiv för Kemi, Mineralogi och Geologi 1949; 26B(no. 14)1–9
  • Pechet L, Alexander B. The Effect of Certain Proteolytic Enzymes on the Thrombin-Fibrinogen Interaction. Biochemistry 1962; 1: 875–83
  • Pisano J J, Finlayson J S, Peyton M P. Cross-link in Fibrin Polymerized by Factor XIII: E-(γ-Glutamyl) Lysine. Science 1968; 160: 892–3
  • Pitcher P M. Crossed Immunoelectrophoresis for the Identification of Fibrinogen Degradation Products. Scandinavian Journal of Haematology 1971; 229–31, Supplementum 13
  • Pizzo S V, Schwartz M L, Hill R L, McKee P A. The Effect of Plasmin on the Subunit Structure of Human Fibrinogen. The Journal of Biological Chemistry 1972a; 247: 636–45
  • Pizzo S V, Schwartz M L, Hill R L, McKee P A. Mechanism of Ancrod Anticoagulation. A Direct Proteolytic Effect on Fibrin. Journal of Clinical Investigation 1972b; 51: 2841–50
  • Pizzo S V, Schwartz M L, Hill R L, McKee P A. The Effect of Plasmin on the Subunit Structure of Human Fibrin. Journal of Biological Chemistry 1973a; 248: 4574–83
  • Pizzo S V, Taylor L M, Schwartz M L, Hill R L, McKee P A. Subunit Structure of Fragment D from Fibrinogen and Crosslinked Fibrin. Journal of Biological Chemistry 1973b; 248: 4584–90
  • Plow E F, Edgington T S. The D:E Complex: A Native Conformational Component of the Fibrinogen Molecule. Thrombosis Research 1972; 1: 605–18
  • Plow E F, Cierniewski C, Edgington T S. The D:E Complex as a Discrete Plasmic Cleavage Product of Fibrinogen. Thrombosis Research 1977; 10: 175–81
  • Rampling M W. Factor XIII Cross-linking and the Rate of Fibrinolysis Induced by Streptokinase and Urokinase. Thrombosis Research 1978; 12: 287–95
  • Rickli E E, Oravski W I. A New Method of Isolation and Some Properties of the Heavy Chain of Human Plasmin. European Journal of Biochemistry 1975; 59: 441–7
  • Robbins K C, Summaria L. Purification of Human Plasminogen and Plasmin by Gel Filtration on Sephadex and Chromatography on Diethylaminoethyl-Sephadex. The Journal of Biological Chemistry 1963; 238: 952–62
  • Robbins K C, Summaria L, Hsieh B, Shah R J. The Peptide Chains of Human Plasmin. Mechanism of Activation of human Plasminogen to Plasmin. The Journal of Biological Chemistry 1967; 242: 2333–42
  • Roschlau W HE. Brinase (CA-7). A New Fibrinolytic Agent. Current Concepts of Coagulation and Hemostasis. Thrombosis et Diathesis haemorrhagia (Stuttg.), R Losito, B Longpré, 1971; 229–41, Supplementum 46
  • Roschlau W HE, Gage R. The Effects of Brinolase (Fibrinolytic Enzyme from Aspergillus Oryzae) on Platelet Aggregation of Dog and Man. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1972; 28: 31–48
  • Salmon J. Etude immunochimique du fibrinogène et de ses dérivés. Clinica Chimica Acta 1959; 4: 767–75
  • Sanchez-Avalos J, Miller S P. Degradation of Fibrinogen by Proteolytic Enzymes. I. Characterization and Isolation of Products and Their Relation to Fibrinolytic States. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1968; 19: 499–515
  • Scheidegger J J. Une micro-méthode de l'immuno-électrophorèse. International Archives of Allergy and Applied Immunology 1955; 7: 103–10
  • Schwartz M L, Pizzo S V, Hill R L, McKee P A. The Effect of Fibrin-Stabilizing Factor on the Subunit Structure of Human Fibrin. Journal of Clinical Investigation 1971a; 50: 1506–13
  • Schwartz M L, Pizzo S V, Hill R L, McKee P A. The Subunit Structures of Human Plasma and Platelet Factor XIII (Fibrin-Stabilizing Factor). The Journal of Biological Chemistry 1971b; 246: 5851–4
  • Schwartz M L, Pizzo S V, Hill R L, McKee P A. Human Factor XIII from Plasma and Platelets. Molecular Weights, Subunit Structures, Proteolytic Activation, and Cross-Linking of Fibrinogen and Fibrin. The Journal of Biological Chemistry 1973; 248: 1395–1407
  • Scully M F, Lane D A, Dubiel M K, Kakkar V V. Role of Subunit Cross-linking in Fibrin Solubility. Biochemical and Biophysical Research Communications 1976; 68: 1206–11
  • Seegers W H, Nieft M L, Vandenbelt J M. Decomposition Products of Fibrinogen and Fibrin. Archives of Biochemistry 1945; 7: 15–9
  • Seligmann M. Possibilité d'étude immunochimique de la fibrinolyse. Revue française d'études cliniques et biologiques 1958; 3: 1073–5
  • Sgouris J T, Inman J K, McCall K B, Hyndman L A, Anderson H D. The Preparation of Human Fibrinolysin (Plasmin). Vox Sanguinis 1960; 5: 357–76
  • Sherry S, Lindemeyer R I, Fletcher A P, Alkjaersig N. Studies on Enhanced Firbinolytic Activity in Man. Journal of Clinical Investigation 1959; 38: 810–22
  • Sjöholm I, Wiman B, Wallen P. Studies on the Conformational Changes of Plasminogen Induced during Activation to Plasmin and by 6-Aminohexanoic Acid. European Journal of Biochemistry 1973; 39: 471–9
  • Summaria L, Arzadon L, Bernabe P, Robbins K C. Studies of the Isolation of the Multiple Molecular Forms of Human Plasminogen and Plasmin by Isoelectric Focusing Methods. The Journal of Biological Chemistry 1972; 247: 4691–702
  • Thorsen S. Differences in the Binding to Fibrin of Native Plasminogen and Plasminogen Modified by Proteolytic Degradation. Influence of W-Aminocarboxylic Acids. Biochimica et Biophysica Acta 1975; 393: 55–65
  • Thorsen S, Müllertz S. Rate of Activation and Electrophoretic Mobility of Unmodified and Partially Degraded Plasminogen. Effects of 6-Aminohexanoic Acid and Related Compounds. Scandinavian Journal of Clinical and Laboratory Investigation 1974; 34: 167–76
  • Triantaphyllopoulos D C. Anticoagulant Effect of Incubated Firbinogen. Canadian Journal of Biochemistry and Physiology 1958; 36: 249–59
  • Tyler H M. Fibrin Crosslinking Demonstrated by Thrombelastography. Thrombosis et Diathesis haemorrhagica (Stuttg.) 1969; 22: 398–400
  • Tyler H M, Lack C H. Studies on the Relationship between Fibrin-Stabilizing Factor, Calcium and Inhibition of Fibrinolysis. Clinical Science 1965; 28: 527–36
  • Vanhoven Ph, Donati M B, Claeys H, Verhaeghe R, Vermylen J. Action of Brinase on Human Fibrinogen and Plasminogen. Thrombosis et Haemostasis (Stuttg.) 1979; 42: 571–81
  • Violand B N, Castellino F J. Mechanism of the Urokinase-Catalyzed Activation of Human Plasminogen. The Journal of Biological Chemistry 1976; 251: 3906–12
  • Wallén P. Chemistry of Plasminogen and Plasminogen Activation. Progress in Chemical Fibrinolysis and Thrombylysis, J F Davidson, R M Rowan, M M Samama, P C Desnoyers. Raven Press, New York 1978; 3: 167–81
  • Wallén P, Iwanaga S. Differences between Plasmic and Tryptic Digests of Human S-sulfo-fibrinogen. Biochimica et Biophysica Acta 1968; 154: 414–7
  • Wallén P, Wiman B. Characterization of Human Plasminogen. II. Separation and Partial Characterization of Different Molecular Forms of Human Plasminogen. Biochimica et Biophysica Acta 1972; 257: 122–34
  • Walther P J, Steinman H M, Hill R L, McKee P A. Activation of Human Plasminogen with Urokinase. Partial Characterization of a Pre-activation Peptide. The Journal of Biological Chemistry 1974; 249: 1173–81
  • Weber K, Osborn M. The reliability of Molecular Weight Determinations by Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis. The Journal of Biological Chemistry 1969; 244: 4406–12
  • Weeke B. Crossed Immunoelectrophoresis. Quantitative Immunoelectrophoresis. Scandinavian Journal of Immunology, N H Axelsen, J Krøll, B Weeke, 1973; 47–56, Supplementum 1
  • Wiman B, Wallén P. Activation of Human Plasminogen by an Insoluble Derivative of Urokinase. Structural Changes of Plasminogen in the Course of Activation to Plasmin and Demonstration of a Possible Intermediate Compound. European Journal of Biochemistry 1973; 36: 25–31
  • Wiman B, Wallén P. The specific Interaction between Plasminogen and Fibrin. A Physiological Role of the Lysine Binding Site in Plasminogen. Thrombosis Research 1977; 10: 213–22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.